US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 245.440
  • +6.570+2.75%
Close Dec 20 16:00 ET
  • 245.440
  • 0.0000.00%
Post 16:59 ET
31.66BMarket Cap-93.68P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alnylam Pharmaceuticals Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
527.02M
500.92M
-26.10M
Miss Est.
-29.78%
-33.26%
-4.95%
EPS
-0.94
-0.87
+0.07
Beat Est.
-179.88%
-175.65%
+7.70%
Analyst Rating
Buy

Dec 21, 2024

Alnylam Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 558.351M--
--2024/Q4-- / 579.267M--
Oct 31, 20242024/Q3500.919M / 527.024M--
Aug 1, 20242024/Q2659.825M / 444.155M--
May 2, 20242024/Q1494.333M / 426.730M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 558.351M--
--2024/Q4-- / 579.267M--
Oct 31, 20242024/Q3500.919M / 527.024M--
Aug 1, 20242024/Q2659.825M / 444.155M--
May 2, 20242024/Q1494.333M / 426.730M--

Unlock Free Earnings Estimates

Alnylam Pharmaceuticals Earnings Reports

  • Alnylam Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31 20:25

  • Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

    Oct 31 20:16

  • Alnylam Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 20:26

  • Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Period Activity

    Aug 1 20:16

    • Read more

    Trending US Stocks
    Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

    Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

    Symbol Mini Chart % Chg
    MicroStrategy
    MSTR
    +11.56%
    NVIDIA
    NVDA
    +3.08%
    Adobe
    ADBE
    +2.24%
    Salesforce
    CRM
    +2.21%
    Apple
    AAPL
    +1.88%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Buy

    • Buy

      76.19%

    • Hold

      19.05%

    • Sell

      4.76%

    Price Target

    No Data